Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 3/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | KDM5A | P29375 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13133182 | 0.85 | ALDH1A1 (0.50) | ALDH1A1EPHX2CNR1DNM1BCHE | |
| SCHEMBL1373497 | 0.83 | ALDH1A1 (0.39) | ALDH1A1HPGDEPHX2CNR1DNM1 | |
| SCHEMBL18232024 | 0.83 | CHRM2 (0.38) | ALDH1A1DNM1MEN1KMT2ABCHE | |
| SCHEMBL1373081 | 0.83 | ALDH1A1 (0.57) | ALDH1A1HPGDLMNA | |
| SCHEMBL1375496 | 0.83 | LMNA (0.39) | ALDH1A1CNR1MEN1KMT2ABCHE | |
| SCHEMBL1373915 | 0.82 | NR1I2 (0.36) | ALDH1A1HPGDEPHX2CNR1DNM1 | |
| SCHEMBL19709756 | 0.81 | ALDH1A1 (0.34) | ALDH1A1MEN1KMT2A | |
| SCHEMBL12209818 | 0.80 | ALDH1A1 (0.42) | ALDH1A1HPGDEPHX2CNR1KDM5A | |
| SCHEMBL1375855 | 0.79 | ALDH1A1 (0.48) | ALDH1A1HPGDLMNA | |
| SCHEMBL1376712 | 0.79 | EPHX2 (0.33) | ALDH1A1HPGDEPHX2CNR1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3728235-B1 | SUBSTITUTED THIOPHENYLURACILS , THEIR SALTS AND USE OF SAID COMPOUNDS AS HERBICIDAL AGENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-02-09 | — | — | EP | disclosed |
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | IDEMITSU KOSAN CO., LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| EP-2837619-A1 | METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE | Idemitsu Kosan Co., Ltd (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8563495-B2 | Resist remover composition and method for removing resist using same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20110287995-A1 | RESIST REMOVER COMPOSITION AND METHOD FOR REMOVING RESIST USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150119604-A1 | METHOD FOR PRODUCING BETA-ALKOXYPROPIONAMIDE | HACL2, APEH, NAAA | ALDH1A1 448/4885HPGD 1082/4885EPHX2 116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.